Page 11234..10..»

Category : Nanomedicine

Nanomedicine Conferences |Nanotechnology Conferences …

Sessions/Tracks

Session 01: Nanomaterials and Nanoparticles

Nanoscale materials are defined as a set of substances where at least one dimension is less than approximately 100 nanometers. A nanometer is one millionth of a millimeter – approximately 100,000 times smaller than the diameter of a human hair. Nanomaterials such as silver and gold nanoparticle are of interest because at this scale unique optical, magnetic, electrical, and other properties emerge. These emergent properties have the potential for great impacts in electronics, medicine, and other fields. The production of nanophase or cluster-assembled materials is usually based upon the creation of separated small clusters which then are fused into a bulk-like material like micelles/liposomes or on their embedding into compact liquid or solid matrix materials.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 02: Intelligent Biomaterials and Smart Implant

A biomaterial is any substance that has processed and engineered to connect with organic frameworks for a medicinal reason – either a helpful (treat, enlarge, repair or supplant a tissue capacity of the body) or an analytic one. As a science, biomaterials is around fifty years of age. It has encountered enduring and solid development over its history, with many organizations putting a lot of cash into the advancement of novel items. Biomaterials science incorporates components of solution, science, tissue designing and materials science. A biomaterial is unique in relation to a natural material, for example, bone, that is delivered by an organic framework.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 03: Nanomedicine in Cancer Therapeutics

Nanomedicine science opens a new pool of opportunities for emerging new technologies in order to diagnose and treat fatal diseases, one of them being nanotechnology in cancer treatment. New nanotechnology enhanced tools are created at much smaller sizes than one of a human cell. With the help of these tools researchers and clinicians may detect the brutal disease of cancer in an earlier stage and move on with its treatment with fewer side effects; potentially cure it before it causes irreversible damage.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

Session 04: Nanofiber Based Scaffolds and Tissue Engineering

Tissue engineering represents an emerging interdisciplinary field that applies the principles of biological, chemical, and engineering sciences towards the goal of tissue regeneration. Creating platforms that copy the design of tissue at the nanoscale is one of the significant difficulties in the field of tissue building. The advancement of nanofibers has significantly improved the degree for creating frameworks that can conceivably address this difficulty. Currently, there are three techniques for the synthesis of nanofibers: electrospinning, self-assembly, and phase separation. Of these techniques, electrospinning is the most widely studied technique and has also demonstrated the most promising results in terms of tissue engineering applications. The major application of nanofiber is that it can be used in controlled drug delivery.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 05: Material Science and Engineering

Materials science is vital to nanotechnology since the properties of electronic photonic and magnetic materials can change significantly when things are made to a great degree little. This perception isn’t just that we have to quantify such properties or grow new preparing apparatuses to create nanodevices, nanosensors and nanosystems. Or maybe, our vision is that the wide (and at times sudden) assortment of wonders related with nanostructured materials enable us to imagine drastically new gadgets and applications that must be made with biocompatible materials.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 06: Nanodrug Delivery for Neurological Disorders

The treatment of neurodegenerative disorders remains a colossal test because of the restricted access of atoms over the blood brain barrier, particularly vast particles, for example, peptides and proteins. Therefore, at most, a little level of a medication that is directed foundationally will achieve the focal sensory system in its dynamic shape. Noninvasive methodologies, for example, nanostructured protein conveyance transporters and intranasal organization, appear to be the most encouraging procedures for the treatment of endless infections, which require long haul mediations. These methodologies are both target-particular and ready to quickly sidestep the blood-brain barrier by means of polymeric micelles or nanogels.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

Session 07: Nanotechnology and Surgery

There are various applications and methods where nanotechnology helps or enhances implants and surgical instrument design. Nanotechnology offers a dream for a ‘shrewd’ medication way to deal with battling tumors: the capacity of nanoparticles to find growth cells and obliterate them with single-cell accuracy. A standout amongst the most critical applications for such nanoparticulate sedate conveyance could be the conveyance of the medication payload into the cerebrum and reconstructive surgery. In any case, crossing the blood-cerebrum obstruction the brain defensive shield is an impressive test. With the assistance of extraordinary nanoparticles, this ends up plainly conceivable.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom.

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 08: Nanometrices for Cell Culture

3D cell culture, recapitulating the length scale of naturally occurring nanotopographic structures, are now being used to elucidate how physical cues can direct cell behaviour and orchestrate complex cellular processes such as stem cell differentiation and tissue organization. Advances in nanotechnology have unlocked our ability to create stimuli-responsive interfaces for spatially and temporally controlling extracellular physical and biochemical cues. Synthetic, natural and cellularised nanofiber scaffolds are used for intracellular sensing and delivery at the sub-cellular level. The field of nanoengineered cellmaterial interface is rapidly evolving, carrying with it the potential for major breakthroughs in fundamental cellular studies and regenerative medicine.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 09: Nanoparticle Based Drug Delivery

Drug delivery systemsare engineered technologies for the targeted drug delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. Biomedical engineers have contributed substantially to our understanding of the physiological barriers to efficient drug delivery, such as transport in the circulatory system and drug movement through cells and tissues; they have also contributed to the development several targeting strategies of drug delivery that have entered clinical practice.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

Session 10: Advanced Nanomaterials

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include synthesis and self assembly of nanomaterials, advanced drug delivery systems, new therapies, and nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicine must be biocompatible for clinical application.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 11: Polymer Nanotechnology

Polymer nanotechnology plays an essential role in synthesizing nanoscale structures and devices. The most important advance in polymer science may be polymers that are doped with nanometre-sized particles to achieve properties superior to conventional polymers. Nanotechnology, polymer matrix based nanocomposites have become a prominent area of current research and development. Research of polymers and nanotechnology primarily focuses on efforts to design materials at a molecular level to achieve desirable properties and applications at a macroscopic level such as polymer-based biomaterials, drug carrier system, nanomedicine, nanoemulsion particles, fuel cell electrode polymer bound catalysts, layer-by-layer self-assembled polymer films, smart polymer, electrospun nanofabrication, imprint lithography, polymer blends, and variety of polymer nanocomposites.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 12: Nanotherapeutics and Diagnosis

Nanotheranostics is a burgeoning field in recent years, which makes use of nanotechnology for diagnostics and therapy of different diseases. The advent of nanotheranostics is expected to benefit the pharmaceutical and healthcare industries in the next 5-10 years. Nanotechnology holds an immense potential to be explored as a multifunctional platform for a wide range of biological and engineering applications such as molecular sensors for disease diagnosis, therapeutic agents for the treatment of diseases, and a vehicle for delivering therapeutics and imaging agents for theranostic applications in cells and living animals.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

ssion 13: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology based system deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptors signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 14: Medical Nanomaterials and Nanodevices

One of the simplest medical nanomaterials is a surface perforated with holes, or nanopores. These pores are large enough to allow small molecules such as oxygen, glucose, and insulin to pass but are small enough to impede the passage of much larger immune system molecules such as immunoglobulins and graft-borne virus particles. Hybrid nanodevice composed of 4.5-nm nanocrystals of biocompatible titanium dioxide semiconductor covalently attached with snippets of oligonucleotide DNA. Both single-walled and multiwalled carbon nanotubes are also being investigated as biosensors; for example, to detect glucose, ethanol, hydrogen peroxide, selected proteins such as immunoglobulins, and an electrochemical DNA hybridization biosensor.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 15: Medical Nanorobotics

The advent of molecular nanotechnology will again expand enormously the effectiveness, comfort, and speed of future medical treatments while at the same time significantly reducing their risk, cost, and invasiveness. MNT will allow doctors to perform direct in vivo surgery on individual human cells. The ability to design, construct, and deploy large numbers of microscopic medical nanorobots will make this possible. Nanobearings and nanogears are perhaps the most convenient class of components to design because their structure and operation is straightforward.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

Session 16: Impact of Nanomedicine on Health Care

The use of nanotechnology to human social insurance, offers various potential pathways to enhancing therapeutic determination and treatment and even to recover tissues and organs. It can totally change the human services segment for the people to come. Nanotechnology will help medicinal experts in the present most intense therapeutic issues, for example, repairing of harmed organs, conclusion and treatment of disease cells, expulsion of obstacle in cerebrum and it can help in better medication conveyance framework. Nanotechnology can be utilized for both in vivo and in vitro biomedical research and applications. Nano particles can be utilized as a part of focusing on tumor cells at beginning stage. Nanotechnology can be utilized to create ”signature protein” to treat tumor.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Session 17: Future Concepts in Nanomedicine

Nanomedicine is promising remarkable things, including great advancements in the treatment of cancer. Imagine a world where there is no donor organ shortage. Where victims of spinal cord injuries can walk, where weakened hearts are replaced. This is the long-term promise of regenerative medicine, a rapidly developing field with the potential to transform the treatment of human disease through the development of innovative new therapies that offer a faster, more complete recovery with significantly fewer side effects or risk of complications.

Related Conference: International Conference on Nanotechnology and Nanomedicine, August 13 – 14, 2019 at Venice, Italy; Global Nanotechnology Congress and Expo, April 15-17, 2019 at Dubai, UAE; Nano Congress for Future Advancements, August 29-31, 2019 at London, UK; Innovate Nanomedicine 2019, February 7-9, 2019 at Hilton Americas, Houston; International Conference on Advanced Nanoscience and Nanotechnology, February 18-19, 2019 at Paris, France; International Conference on Nanoscience and Nanotechnology, March 28-29, 2019 at Paris, France; International Nanotechnology Conference & Expo, April 3-5, 2019 at Philadelphia, USA.

Related Societies: Semiconductor Industry Association (SIA), National Cancer Institute, Alliance for Nanotechnology in Cancer, National Institutes of Health, Nanomedicine Roadmap Initiative, American National Standards Institute Nanotechnology Panel (ANSI-NSP), National Nanotechnology Initiative

Session 18: Ethical and Social Aspects of Nanomedicine

Nanomedicine offers the possibility of new diagnostic, treatment and preventive methods that may open up promising areas of medicine. The scope of this Opinion is ethical issues raised by nanomedicine in the sense indicated by the European Science Foundation definition quoted in the introduction. Fundamental values and rights are rooted in the principle of human diginity and shed light on core Europeon values, such as integrity, autonomy, privacy, equity, fairness, pluralism and solidarity.

Related Conference: World Nanotechnology Congress and Expo, April 25-26, 2019 at Valencia, Spain; International Conference on Semiconductors, Optoelectronics and Nanostructures, August 19-20, 2019 at Barcelona, Spain; International Conference On Nano Technology and Nano Engineering, April 24-25, 2019 at Vancouver, Canada; International Conference on Theoretical and Applied Nanoscience and Nanotechnology, June 13-14, 2019 at Ottawa, Canada; International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, October 04-06, 2018 at Moscow, Russia; International Conference on Nanotechnology: Fundamentals and Applications, August 18 – 20, 2019 at Lisbon, Portugal; International Conference on Sensor and Nanotechnology, July 24-25, 2019 at Pulau Pinang, Singapore.

Related Societies: Center for Biological and Environmental Nanotechnology, Center for Integrative Nanotechnology Sciences, Center for Nanostructure Characterization and Fabrication, Center for Nanotechnology in Society, Institute for Nanoscale and Quantum Scientific and Technological Advanced Research (nanoSTAR), Institute for Soldier Nanotechnologies, Nanofabrication Facility

Session 19: Applications of Nanobiotechnology to Clinical Science

Nanobiotechnology is the application of nanotechnology in biological fields. Nanobiotechnology has huge number of possibilities for propelling restorative science in this manner enhancing human services hones the world over. Numerous novel nanoparticles and nanodevices are relied upon to be utilized, with a gigantic positive effect on human wellbeing. While genuine clinical uses of nanotechnology are still for all intents and purposes inexistent, a noteworthy number of promising therapeutic undertakings are in a progressed trial organize. Usage of nanotechnology in solution and physiology implies that instruments and gadgets are so actually composed that they can communicate with sub-cell (i.e. sub-atomic) levels of the body with a high level of specificity. Subsequently remedial viability can be accomplished to most extreme with insignificant reactions by methods for the focused on cell or tissue-particular clinical mediation.

Related Conference: International Conference on Advanced Material Research and Nanotechnology, September 17-18, 2018 at Berlin, Germany; World Nanotechnology conference, April 15-16, 2019 at Dubai, UAE; International Nanomedicine and Drug Delivery Symposium, September 21-23, 2018 at Portland, Oregon; International Conference and Exhibition on Nanomedicine and Nanotechnology, October 15-17, 2018 at Tokyo, Japan; 3rd International Conference on Nanostructures, Nanomaterials and Nanoengineering, December 03-04, 2018 at Toronto, Canada; NANO Boston Conference, April 22-24, 2019 at Boston, MA, USA; International Conference on Biomaterials, Colloids and Nanomedicine, August 20 – 21, 2019 at London, United Kingdom

Related Societies: American Chemical Society, Nanotechnology Safety Resources, American Society for Precision Engineering (ASPE), Converging Technologies Bar Association, Graphene Stakeholders Association, IEEE (Institute of Electrical and Electronics Engineers), International Association of Nanotechnology (IANT), Materials Research Society

Read the original:
Nanomedicine Conferences |Nanotechnology Conferences …

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine | Ardena

This fast-evolving field uses nanoscale or nanostructured materials to impart unique pharmacokinetic and therapeutic effects such as enhanced dissolution rate and oral bioavailability, targeted delivery, enhanced efficacy and reduced toxicity.

The control of materials in the nanometer size range requires scientifically demanding chemistry, analysis and manufacturing techniques. Our nanomedicine expertise encompasses formulation, process and analytical development, GMP manufacturing and dossier development.

We are experts in the following formulations:

Once we identify a suitable formulation, our scientists develop phase-appropriate production processes in accordance with cGMP and mitigate technology transfer issues by using the same teams for development and manufacturing.

Techniques include:

In our cGMP-compliant manufacturing facilities, we can produce volumes of a couple of millilitres to multiple litres, using batch-type and continuous-flow processes. We also work with highly-potent drug substances and can deliver nanosuspensions and nanoparticle solutions as sterile finished drug products in vials or syringes.

To support product development and to perform quality control of GMP-produced drug products, we utilise state-of-the-art analytical techniques such as:

Having advanced a wide range of nanomedicine formulations into the clinic, we are used to developing new manufacturing techniques and analytical procedures under fierce regulatory scrutiny. Our understanding of the regulatory landscape gives your nanomedicine project the greatest chance of approval.

Read the original here:
Nanomedicine | Ardena

Recommendation and review posted by Alexandra Lee Anderson

Nanobots in medicine: the key to fighting chronic diseases …

Nanomedicine is a domain of medicine that utilises the knowledge of nanotechnology to prevent and treat severe diseases such as cancer and heart diseases. Recent advances in nanotechnology have enabled doctors to use nanoscale materials, including biocompatible nanoparticles and nanobots in medicine, to sense the actuation purposes in a living organism. Moreover, further developments in the nanomedicine market can create opportunities such as the development of artificial antibodies and artificial RBCs and WBCs

Nanomedicine is a domain of medicine that utilises the knowledge of nanotechnology to prevent and treat severe diseases such as cancer and heart diseases. Recent advances in nanotechnology have enabled doctors to use nanoscale materials, including biocompatible nanoparticles and nanobots, to sense the actuation purposes in a living organism.

In addition, researchers now use nanomedicines to boost immunotherapy. In recent years, ample innovations have emerged from the field of nanomedicine, which has boosted the nanomedicine market. According to Allied Market Research, the nanomedicine market was valued at $111.91bn (~95.39bn) in 2016, and is expected to reach $261.06bn by the end of 2023, registering a CAGR of 12.6% in the period of 20172023.

From improving the quality of solar panels to treating cancer, quantum dots are widely used in various sectors. However, creating quantum dots is an extremely expensive process which generates a huge amount of waste. However, scientists have recently developed a low-cost method to synthesise quantum dots using some chemicals and green leaf extracts.

A team of scientists at Wales Swansea University developed an economical and environment-friendly way to produce quantum dots from Camellia sinensis leaf extract.

This innovative method makes the procedure economical and the byproducts are non-toxic. The research proved that the quantum dots created with tea leaves can penetrate the skin and reduce the growth of cancer cells by about 80%.

However, while this study does not provide the ultimate cure for cancer, the major issues with the production of quantum dots such as high cost and toxic byproducts are solved. In addition, in-depth research can present new possibilities in treating different diseases and developing more advanced technology.

Scientists have also created fucoidan-based magnetic nanomedicines that can offer effective treatment for cancer.

Taiwans National Chiao Tung University (NCTU) and the China Medical University have successfully developed an innovative way to cure cancer by combining nanomedicines with immunotherapy. The research, titled Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumor-localized immunotherapy is published in the renowned journal Nature Nanotechnology.

This study is seen as a significant breakthrough to boost tumour treatment.

Immunotherapy can cause severe side-effects including stomach sickness and skin blistering as sometimes healthy cells get attacked by the immune system. Therefore, researchers combined fucoidan-based magnetic nanomedicine with immunotherapy. The results proved that such combination successfully contains the cancer cells while boosting the growth of healthy cells, which in turn reduces the side-effects and increases the efficiency of treatment.

Nanomedicines most important breakthrough can be regarded as nanobots. Nanobots serve as miniature surgeons which can be used to repair damaged cells or entirely replace intracellular structures. Moreover, they can replicate themselves to correct a genetic deficiency or replace DNA molecule to eradicate disease. Scientists claim that a fleet of nanobots can serve as antibodies or antiviral agents to treat patients with an impaired immune system. Investigating nanobots in medicine can create lucrative opportunities in healthcare such as unblocking arteries or completely replacing an organ.

Conventional water-soluble drugs can create difficulties in treatment, such as failed absorption in the diseased areas. However, nanomedicine applications such as diagnostic nanomachines provide the ability to monitor the internal chemistry of the bodys organs, providing direct access to diseased areas. Moreover, technology such as nanobots can be equipped with wireless transmitters, and this offers doctors opportunities to change the treatment method if a patients medical condition gets worse. Nanobots in medicine could also be planted into a patients nervous system to monitor pulse and brainwave activities.

According to scientists, nanobots can completely replace pacemakers by treating the hearts cell directly. Research regarding nanobots in medicine offer several opportunities such as artificial antibodies, artificial white blood cells (WBCs) and red blood cells (RBCs), and antiviral nanobots. The major advantage that nanobots provide is that they are extremely durable. Theoretically, they can operate for years without any damage owing to their miniature size, which reduces mechanical damage.

The advantages of nanobots and nanomedicines are enormous. Therefore, several leading companies are investing in research and development in this area. Not long ago, Vancouver-based company Precision NanoSystems closed a $6m project to fund a nanomedicine manufacturing platform, NanoAssemblr. The company is recognised for its research into the genetic basis of diseases and the development of nanoparticles for drugs.

The CEO and co-founder of Precision NanoSystems said: NanoAssemblr technology will offer a solution for the discovery, development, and manufacture of nanomedicine. This additional funding will enable us to develop new products at lower costs and grow customer base.

Such strategic collaboration on the part of leading companies has boosted the growth of the nanomedicine market.

Swamini KulkarniAllied Market ResearchTweet @marketresearcht https://www.alliedmarketresearch.com/

This article will appear in issue 7 of Health Europa Quarterly, which will be published in November 2018.

More here:
Nanobots in medicine: the key to fighting chronic diseases …

Recommendation and review posted by Alexandra Lee Anderson

International Journal of Nanomedicine | Volume 13 – Dove Press

Silicagentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

Mosselhy DA, He W, Hynnen U, Meng Y, Mohammadi P, Palva A, Feng QL, Hannula SP, Nordstrm K, Linder MB

International Journal of Nanomedicine 2018, 13:8577-8578

Published Date: 13 December 2018

Strojny B, Sawosz E, Grodzik M, Jaworski S, Szczepaniak J, Sosnowska M, Wierzbicki M, Kutwin M, Orliska S, Chwalibog A

International Journal of Nanomedicine 2018, 13:8561-8575

Published Date: 13 December 2018

Belle Ebanda Kedi P, Eya’ane Meva F, Kotsedi L, Nguemfo EL, Bogning Zangueu C, Ntoumba AA, Mohamed HEA, Dongmo AB, Maaza M

International Journal of Nanomedicine 2018, 13:8537-8548

Published Date: 12 December 2018

Wu M, Liu J, Hu C, Li D, Yang J, Wu Z, Yang L, Chen Y, Fu S, Wu J

International Journal of Nanomedicine 2018, 13:8461-8472

Published Date: 11 December 2018

Perera PGT, Nguyen THP, Dekiwadia C, Wandiyanto JV, Sbarski I, Bazaka O, Bazaka K, Crawford RJ, Croft RJ, Ivanova EP

International Journal of Nanomedicine 2018, 13:8429-8442

Published Date: 10 December 2018

Shen Y, Yu Y, Chaurasiya B, Li X, Xu Y, Webster TJ, Tu J, Sun R

International Journal of Nanomedicine 2018, 13:8281-8296

Published Date: 5 December 2018

Yan J, Zhang H, Cheng F, He Y, Su T, Zhang X, Zhang M, Zhu Y, Li C, Cao J, He B

International Journal of Nanomedicine 2018, 13:8247-8268

Published Date: 4 December 2018

Renu S, Markazi AD, Dhakal S, Lakshmanappa YS, Gourapura SR, Shanmugasundaram R, Senapati S, Narasimhan B, Selvaraj RK, Renukaradhya GJ

International Journal of Nanomedicine 2018, 13:8195-8215

Published Date: 30 November 2018

Mosselhy DA, He W, Hynnen U, Meng Y, Mohammadi P, Palva A, Feng QL, Hannula SP, Nordstrm K, Linder MB

International Journal of Nanomedicine 2018, 13:7939-7957

Published Date: 28 November 2018

Wang Y, Chen H, Zhang X, Gui L, Wu J, Feng Q, Peng S, Zhao M

International Journal of Nanomedicine 2018, 13:7835-7844

Published Date: 22 November 2018

Lu MM, Ge YR, Qiu J, Shao D, Zhang Y, Bai J, Zheng X, Chang ZM, Wang Z, Dong WF, Tang CB

International Journal of Nanomedicine 2018, 13:7697-7709

Published Date: 19 November 2018

Yuan Z, Yuan Y, Han L, Qiu Y, Huang X, Gao F, Fan G, Zhang Y, Tang X, He X, Xu K, Yin P

International Journal of Nanomedicine 2018, 13:7533-7548

Published Date: 15 November 2018

Wang B, Guo Y, Chen X, Zeng C, Hu Q, Yin W, Li W, Xie H, Zhang B, Huang X, Yu F

International Journal of Nanomedicine 2018, 13:7395-7408

Published Date: 12 November 2018

Li D, Zhang K, Shi C, Liu L, Yan G, Liu C, Zhou Y, Hu Y, Sun H, Yang B

International Journal of Nanomedicine 2018, 13:7167-7181

Published Date: 6 November 2018

Kim DH, Kim JY, Kim RM, Maharjan P, Ji YG, Jang DJ, Min KA, Koo TS, Cho KH

International Journal of Nanomedicine 2018, 13:7095-7106

Published Date: 5 November 2018

Horvth T, Papp A, Igaz N, Kovcs D, Kozma G, Trenka V, Tiszlavicz L, Rzga Z, Knya Z, Kiricsi M, Vezr T

International Journal of Nanomedicine 2018, 13:7061-7077

Published Date: 2 November 2018

Lee D, Heo DN, Nah HR, Lee SJ, Ko WK, Lee JS, Moon HJ, Bang JB, Hwang YS, Reis RL, Kwon IK

International Journal of Nanomedicine 2018, 13:7019-7031

Published Date: 1 November 2018

Wang W, Nie W, Liu D, Du H, Zhou X, Chen L, Wang H, Mo X, Li L, He C

International Journal of Nanomedicine 2018, 13:7003-7018

Published Date: 1 November 2018

Lu Y, Jiang W, Wu X, Huang S, Huang Z, Shi Y, Dai Q, Chen J, Ren F, Gao S

International Journal of Nanomedicine 2018, 13:6913-6927

Published Date: 30 October 2018

Shi Ms, Zhao X, Zhang J, Pan S, Yang C, Wei Y, Hu H, Qiao M, Chen D, Zhao X

International Journal of Nanomedicine 2018, 13:6885-6902

Published Date: 26 October 2018

Nejadi Babadaei MM, Feli Moghaddam M, Solhvand S, Alizadehmollayaghoob E, Attar F, Rajabbeigi E, Akhtari K, Sari S, Falahati M

International Journal of Nanomedicine 2018, 13:6871-6884

Published Date: 26 October 2018

Vio V, Riveros AL, Tapia-Bustos A, Lespay-Rebolledo C, Perez-Lobos R, Muoz L, Pismante P, Morales P, Araya E, Hassan N, Herrera-Marschitz M, Kogan MJ

International Journal of Nanomedicine 2018, 13:6839-6854

Published Date: 25 October 2018

Qiu W, Chen R, Chen X, Zhang H, Song L, Cui W, Zhang J, Ye D, Zhang Y, Wang Z

International Journal of Nanomedicine 2018, 13:6809-6827

Published Date: 24 October 2018

Sun L, Xu J, Sun Z, Zheng F, Liu C, Wang C, Xiaoye Hu, Xia L, Liu Z, Xia R

International Journal of Nanomedicine 2018, 13:6769-6777

Published Date: 24 October 2018

Song Y, Ma A, Ning J, Zhong X, Zhang Q, Zhang X, Hong G, Li Y, Sasaki K, Li C

International Journal of Nanomedicine 2018, 13:6751-6767

Published Date: 23 October 2018

Dhakal S, Cheng X, Salcido J, Renu S, Bondra K, Lakshmanappa YS, Misch C, Ghimire S, Feliciano-Ruiz N, Hogshead B, Krakowka S, Carson K, McDonough J, Lee CW, Renukaradhya GJ

International Journal of Nanomedicine 2018, 13:6699-6715

Published Date: 24 October 2018

Rodallec A, Sicard G, Giacometti S, Carr M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R

International Journal of Nanomedicine 2018, 13:6677-6688

Published Date: 23 October 2018

Zhao X, Qi T, Kong C, Hao M, Wang Y, Li J, Liu B, Gao Y, Jiang J

International Journal of Nanomedicine 2018, 13:6413-6428

Published Date: 12 October 2018

Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, You Y, Wang S, Chen X, Sui X, Xie T

International Journal of Nanomedicine 2018, 13:6279-6296

Published Date: 10 October 2018

Zhou X, Shi G, Fan B, Cheng X, Zhang X, Wang X, Liu S, Hao Y, Wei Z, Wang L, Feng S

International Journal of Nanomedicine 2018, 13:6265-6277

Published Date: 10 October 2018

Hernandez-Delgadillo R, Garca-Cuellar CM, Snchez-Prez Y, Pineda-Aguilar N, Martnez-Martnez MA, Rangel-Padilla EE, Nakagoshi-Cepeda SE, Sols-Soto JM, Snchez-Njera RI, Nakagoshi-Cepeda MAA, Chellam, S, Cabral-Romero C

International Journal of Nanomedicine 2018, 13:6089-6097

Published Date: 5 October 2018

Kuroda C, Ueda K, Haniu H, Ishida H, Okano S, Takizawa T, Sobajima A, Kamanaka T, Yoshida K, Okamoto M, Tsukahara T, Matsuda Y, Aoki K, Kato H, Saito N

International Journal of Nanomedicine 2018, 13:6079-6088

Published Date: 5 October 2018

Yamoah MA, Moshref M, Sharma J, Chen WC, Ledford HA, Lee JH, Chavez KS, Wang W, Lpez JE, Lieu DK, Sirish P, Zhang XD

International Journal of Nanomedicine 2018, 13:6073-6078

Published Date: 5 October 2018

View post:
International Journal of Nanomedicine | Volume 13 – Dove Press

Recommendation and review posted by Alexandra Lee Anderson

The Promise of Nanomedicine – Laboratory Equipment

More than a decade ago, nanotechnology became an integral part of the overall scientific research world. Governments started funding programs specifically aimed at nanotechnology, research universities opened their facilities and coursework to the new discipline, and journals focusing on nano research became commonplace.And now, many researchers believe, its nanomedicines turn to do the same. Nanomedicinewhich has emerged as nanotechnologys most important sub-disciplineis the application of nanotechnology to the prevention and treatment of disease in the human body. It is already having an impact clinically among some of the deadliest diseases in the world.

Nanomedicine is far from the stuff of science fiction. The possibilities for nanomedicine to help us diagnose, treat and image diseases are endless. Imagine a smart nanomedicine that is able to bind to tumor cells and enhance imaging and diagnosis, at the same time as being able to deliver a gene therapy or chemotherapy agent. With the technologies available to us and our multidisciplinary teams, this will be possible in my lifetime, said Phoebe Phillips, head of the pancreatic cancer translational research group at the University of New South Wales in Sydney.

Phillips and her team have created a nanoparticle that dramatically increases its effectiveness as an anti-cancer drug for patients with pancreatic cancers, which is one of the fastest killing cancers from time of initial detection, often leaving patients with no suitable treatment options and only weeks to live.

While nanomedicine canand likely willplay a role in diagnostics, regenerative medicine, prosthetics and more, the effect the sub-discipline is currently having on the treatment of autoimmune diseases and cancers is significant.

Nanomedicine for HIVThirty years ago, a diagnosis of HIV/AIDS was essentially a guarantee of a painful, protracted death. It wasnt until 1996 that researchers discovered antiretroviral drugs, and the potent combination therapy that leads to successful management of HIV/AIDS in most cases. However, not much has changed since that discovery. Those suffering from the autoimmune disease still require daily oral dosing of three to four pills, and chronic oral dosing has significant complications that can arise from the high pill burden experienced by patients, leading to non-adherence to therapies for a variety of reasons.

Ive been working in HIV for over 20 years, Andrew Owen, professor of molecular and clinical pharmacology at the University of Liverpool (UK) told Laboratory Equipment. I was trying to understand the variability in drug exposure that occurs between different individuals and the genetic basis for that. We were finding a lot of interesting things, but they werent clinically implementable. They gave us a good understanding of why drug exposure was variable, but it didnt actually help the patients in any way.

In an attempt to solve the problem rather than just characterize it, Owen turned to nanomedicine in 2009, eventually becoming part of the first team to conduct human trials of orally dosed nanomedicines for HIV. Since then, Owen and his interdisciplinary team at the Liverpool Nanomedicine Partnership have secured more than 20 million of research funding for a multitude of nanomedicine-based approaches to HIV, such low-dose oral delivery, long-acting injectable medications and targeted delivery of antiretrovirals.

Some of Owens most important research to date tackles two of the pharmaceutical industrys biggest challenges: oral delivery of potent drugs and supply and demand.

One of the major problems that has plagued drug discovery and drug development over the last 30 years has been compatibility with oral drug delivery, Owen explained. The pharmaceutical industry has wrestled with that because they can develop very potent molecules across diseases, but actually delivering those molecules orally is very challenging. As you try to design into the molecule oral bioavailabilty, you usually get further away from the potency you want.

The Liverpool team solved this problem with the creation of Solid Drug Nanoparticles. The technology consists of combining a normal drug, in its solid form, with particles on that drug that are measurable within the nanometer scale. There are other things packed into the formulation as well, such as FDA-approved stabilizers that are proven to help disperse the drug. Owen says it is all about increasing the surface area covered by the drug.

If you imagine you take a granulated form of the drug, youre going to get big chunks of drugs in the intestinal tract when dissolution happens. But if you have nanometer-sized particles within the GI tract, then you are going to get a complete coating of the inside of the intestine after you take the drug, Owen explained. What that does is it massively increases the surface area covered by the drug, which saturates all sorts of drug influx processes within the GI tract.

Since 80 percent of a humans immune system is concentrated in the gut, the Solid Drug Nanoparticles are the perfect mechanism. The immune cells in the gut instinctually move toward the particles, creating a pathway for the drugs to cross the intestines, move through the lymphatic system, and finally into the systematic circulation.

In February, Owen presented the results of two trials at the Conference on Retroviruses and Opportunistic Infections (CROI) that confirmed his Solid Drug Nanoparticles can be effective at a 50 percent dose reduction. Specifically, Owen and his team applied the nanomedicine-based approach to the formulation of two drugs: efvirenz (EFV) and lopinavir (LPV). EFV is the current WHO-recommended regimen, with 70 percent of adult HIV patients in low- and middle-income countries taking the medication. At 50 percent of the dose, the patients in the trial were able to maintain plasma concentrations of the conventional dose.

Globally, the supply of drugs needed to treat every patient with HIV is outstripping manufacturing capabilitymeaning we, as a human species, cannot physically make enough HIV medication to treat everyone with the disease. A 50 percent reduction in dose means twice as many patients served with the existing drug supply.Owen and his team are working with multiple global partners to move the technology forward. For the drugs already formulated, the Medicines Patent Pool and Clinical Health Access are helping to scale up and take them to market. Meanwhile, USAIDs Project OPTIMIZE is applying the nanoparticle technology to the newest HIV drugs for use in low- and middle-income countries.

For their latest collaboration with Johns Hopkins University, the Liverpool team was just awarded $3 million to examine the use of implantable technologies that can deliver drugs for weeks, or even months.

The current oral drug regimens for HIV comprises three drugs in combinationone is the major driver for efficacy, and the other two are nucleoside reverse transcriptase inhibitors that prevent resistance to the main drug. However, current injectable formulations are only available with the main drugnone include the nucleoside reverse transcriptase inhibitors.

So, our project aims to develop the first long-acting injectable nucleoside reverse transcriptase inhibitors so that we can use them to have a fully long-acting regimen that matches the current clinical paradigm for therapy, Owen said.

The Liverpool/Hopkins team has also thought about applying their long-acting injectable technology to other chronic diseases, such as malaria and tuberculosis, as well as some cardiovascular applications.

Nanomedicine for diabetesWhen the nanoparticles he was working with as an imaging tool didnt produce the desired results, Pere Santamaria grew frustratedbut he didnt give up. Instead, the doctor and professor at the University of Calgary (Canada) changed his assumptions and pursued his experimentuntil the data came pouring in that confirmed it wasnt a failed experiment at all. Rather, it was a discovery.

The discovery of Navacims was a bit serendipitous, Santamaria told Laboratory Equipment. Thankfully I am a little OCD and I didnt let the failed experiment go.Navacims are an entirely new class of nanomedicine drugs that harness the ability to stop disease without impairing normal immunity. Santamaria has been studying Navacims for the past 17 years, ever since unintentionally developing them. He even started a spin-off company, Parvus Therapeutics, Inc., to help bring the drugs to market.

In autoimmune diseases, white blood cells, which are normally responsible for warding off foreign invaders and disease, turn on the body, attacking the good cells and causing their destruction. Each specific autoimmune disease results from an attack against thousands of individual protein fragments in the targeted organ, such as the insulin-producing pancreatic cells in the case of type 1 diabetes.

But Santamarias studies show that nanoparticles decorated with protein targets acting as bait for disease-causing white blood cells can actually be used to reprogram the cells to rightfully suppress the disease they once intended to cause.

Once the immune system recognizes the presence of a Navacim, a white blood cell is reprogrammed by epigenetic changes into a lymphocyte that no longer wants to cause tissue damage, but rather work to suppress disease. According to Santamaria, the reprogramming step is immediately followed by an expansion of that population of lymphocytesone now-good white blood cell dividing into a million.

Basically they turn the tables on the immune system, and then there is a very sophisticated series of downstream cellular events that arise from that reprogramming event that involves the recruitment of other lymphocytes and other cell types that completely suppress the inflammation in the organ that is being infected, Santamaria explained. This happens extremely efficiently and comprehensively. This is an approach that can efficiently, selectively and specifically blend a complex response without impairing basic immunity.

In addition, the design of Navacims is modular, meaning the nanomedicine can be applied to severalif not allautoimmune diseases, including multiple sclerosis and rheumatoid arthritis. Navacims can be altered to target different diseases by simply changing a small portion of the bait molecules on the nanoparticles. Santamarias studies have shown this to work in about seven autoimmune diseases thus far.

In April, Santamarias company Parvus entered into a license and collaboration agreement with Novartis for Navacims. Under the terms of the agreement, Novartis receives exclusive worldwide rights to use Parvus Navacim technology to develop and commercialize products for the treatment of type 1 diabetes, and will be responsible for clinical-stage development and commercialization. Parvus will still be responsible for conducting ongoing preclinical work in the diabetes area, with some research funding from Novartis.

Weve had such a long time to prove ourselves, that this is not a flash in the pan, that this is something serious and robust, Santamaria said. We know so much about the mechanisms of our actions, and so much granularity. I think there are no other drugs that have reached the clinic with this level of understanding. That was painful in the beginning for us, but in the end its going to be good.

Read more:
The Promise of Nanomedicine – Laboratory Equipment

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine | The Scientist Magazine

LAGUNA DESIGN/SCIENCE PHOTO LIBRARY/CORBIS

In a 1959 lecture at Caltech famously dubbed Theres Plenty of Room at the Bottom, American physicist and Nobel laureateto-be Richard Feynman discussed the idea of manipulating structures at the atomic level. Although the applications he discussed were theoretical at the time, his insights prophesied the discovery of many new properties at the nanometer scale that are not observed in materials at larger scales, paving the way for the ever-expanding field of nanomedicine. These days, the use of nanosize materials, comparable in dimension to some proteins, DNA, RNA, and oligosaccharides, is making waves in diverse biomedical fields, including biosensing, imaging, drug delivery, and even surgery.

Nanomaterials typically have high surface areato-volume ratios, generating a relatively large substrate for chemical attachment. Scientists have been able to create new surface characteristics for nanomaterials and have manipulated coating molecules to fine-tune the particles behaviors. Most nanomaterials can also penetrate living cells, providing the basis for nanocarrier delivery of biosensors or therapeutics. When systemically administered, nanomaterials are small enough that they dont clog blood vessels, but are larger than many small-molecule drugs, facilitating prolonged retention time in the circulatory system. With the ability to engineer synthetic DNA, scientists can now design and assemble nanostructures that take advantage of ?Watson-Crick base pairing to improve target detection and drug delivery.

Both the academic community and the pharmaceutical industry are making increasing investments of time and money in nanotherapeutics. Nearly 50 biomedical products incorporating nanoparticles are already on the market, and many more are moving through the pipeline, with dozens in Phase 2 or Phase 3 clinical trials. Drugmakers are well on their way to realizing the prediction of Christopher Guiffre, chief business officer at the Cambridge, Massachusettsbased nanotherapeutics company Cerulean Pharma, who last November forecast, Five years from now every pharma will have a nano program.

Technologies that enable improved cancer detection are constantly racing against the diseases they aim to diagnose, and when survival depends on early intervention, losing this race can be fatal. While detecting cancer biomarkers is the key to early diagnosis, the number of bona fide biomarkers that reliably reveal the presence of cancerous cells is low. To overcome this challenge, researchers are developing functional nanomaterials for more sensitive detection of intracellular metabolites, tumor cellmembrane proteins, and even cancer cells that are circulating in the bloodstream. (See Fighting Cancer with Nanomedicine, The Scientist, April 2014.)

The extreme brightness, excellent photostability, and ready modulation of silica nanoparticles, along with other advantages, make them particularly useful for molecular imaging and ultrasensitive detection.

Silica nanoparticles are one promising material for detecting specific molecular targets. Dye-doped silica nanoparticles contain a large quantity of dye molecules housed inside a silica matrix, giving an intense fluorescence signal that is up to 10,000 times greater than that of a single organic fluorophore. Taking advantage of Frster Resonance Energy Transfer (FRET), in which a photon emitted by one fluorophore can excite another nearby fluorophore, researchers can synthesize fluorescent silica nanoparticles with emission wavelengths that span a wide spectrum by simply modulating the ratio of the different dyesthe donor chromophore and the acceptor chromophore. The extreme brightness, excellent photostability, and ready modulation of silica nanoparticles, along with other advantages, make them particularly useful for molecular imaging and ultrasensitive detection.

THE NANOMEDICINE CABINET: Scientists are engineering nanometer-size particles made of diverse materials to aid in patient care. The unique properties of these structures are making waves in biomedical analysis and targeted therapy.See full infographic: JPG | PDF TAMI TOLPAOther materials that are under investigation as nanodetectors include graphene oxide (GO), the monolayer of graphite oxide, which has unique electronic, thermal, and mechanical properties. Semiconductor-material quantum dots (QDs), now being developed by Shuming Nies group at Emory University, exhibit quantum mechanical properties when covalently coupled to biomolecules and could improve cancer imaging and molecular profiling.1 Spherical nucleic acids (SNAs), in which nucleic acids are oriented in a spherical geometry, scaffolded on a nanoparticle core (which may be retained or dissolved), are also gaining traction by the pioneering work of Chad Mirkins group at Northwestern University.2 (See illustration.)

Nanoparticles are also proving their worth as probes for various types of bioimaging, including fluorescence, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). For instance, Xiaoyuan Chen, now at the National Institutes of Healths National Institute of Biomedical Imaging and Bioengineering, and Hongjie Dai of Stanford University have developed carbon nanotubes for performing PET scans in mice. When modified with the macromolecule polyethylene glycol to improve biocompatibility, the nanotubes were very stable and remained in circulation for days, far longer than the few hours typical of many molecular imaging agents.3 Further modification with a short-peptide targeting ligand called RGD caused the nanotubes to selectively accumulate in tumors that overexpressed integrin, the molecular target of RGD, enabling precise tumor imaging.

To further increase the specificity of nanodetectors, researchers can add recognition probes such as aptamersshort synthetic nucleic acid strands that bind target molecules. For example, we conjugated gold nanoparticles with aptamers that had been identified through iteratively screening DNA probes using living cancer cells.4 Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors and provide a potential target for early cancer diagnosis. However, CTCs are rare, with blood concentrations of typically fewer than 10 cells per milliliter of blood. Collaborating with physicians to profile samples from leukemia patients, we demonstrated that aptamers are capable of differentiating among different subtypes of leukemia, as well as among patient samples before and after chemotherapy (unpublished data). In addition to leukemia, we have selected aptamers specific to cancers of the lung, liver, ovaries, colon, brain, breast, and pancreas, as well as to bacterial cells. Other researchers have developed nanoparticles with numerous and diverse surface aptamers, enabling them to bind their targets more efficiently and securely.

NANOCAPSULES: A false-color transmission electron micrograph of liposomes, spherical particles composed of a lipid bilayer around a central cavity that can be engineered to deliver both hydrophobic and hydrophilic drugs to specific cells in the body DAVID MCCARTHY/SCIENCE SOURCEThe prototype of targeted drug delivery can be traced back to the concept of a magic bullet, proposed by chemotherapy pioneer and 1908 Nobel laureate Paul Ehrlich. Ehrlich envisioned a drug that could selectively target a disease-causing organism or diseased cells, leaving healthy tissue unharmed. A century later, researchers are developing many types of nanoscale magic bullets that can specifically deliver drugs into target cells or tissues.

Doxil, the first nanotherapeutic approved by the US Food and Drug Administration, is a liposome (~100 nm in diameter) containing the widely used anticancer drug doxorubicin. The therapy takes advantage of the leaky blood vasculature and poor lymphatic drainage in tumor tissues that allow the nanoparticles to squeeze from blood vessels into a tumor and stay there for hours or days. Scientists have also been developing nanotherapeutics capable of targeting specific cell types by binding to surface biomarkers on diseased cells. Targeting ligands range from macromolecules, such as antibodies and aptamers, to small molecules, such as folate, that bind to receptors overexpressed in many types of cancers.

Aptamers in particular are a popular tool for targeting specific cells. Aptamer development is efficient and cost-effective, as automated nucleic acid synthesis allows easy, affordable chemical synthesis and modification of functional moieties. Other advantages include high stability and long shelf life, rapid tissue penetration based on the relatively small molecular weights, low immunogenicity, and ease of antidote development in the case of an adverse reaction to therapy by simply administering an aptamers complementary DNA. We have demonstrated the principle of modifying aptamers on the surfaces of doxorubicin-containing liposomes, which then selectively delivered the drug to cultured cancer cells.5

Recent advances in predicting the secondary structures of a DNA fragment or interactions between multiple DNA strands, as well as in technologies to automatically synthesize predesigned DNA sequences, has opened the door to more advanced applications of aptamers and other DNA structures in nanomedicine. For instance, we have developed aptamer-tethered DNA nanotrains, assembled from multiple copies of short DNA building blocks. On one end, an aptamer moiety allows specific target cell recognition during drug delivery, and a long double-stranded DNA section on the other end forms the boxcars for drug loading. The nanotrains, which can hold a high drug payload and specifically deliver anticancer drugs into target cancer cells in culture and animal models,6 could reduce drug side effects while inhibiting tumor growth. Alternatively, Daniel Anderson of MIT engineered a tetrahedral cage of DNA, often called DNA origami, for folate-mediated targeted delivery of small interfering RNAs (siRNAs) to silence some tumor genes.7 And Mirkins SNAs can similarly transport siRNAs as guided missiles to knock out overexpressed genes in cancer cells. Mirkins group also recently demonstrated that the SNAs were able to penetrate the blood-brain barrier and specifically target genes in the brains of glioblastoma animal models.2 Peng Yin of Harvard Medical School and the Wyss Institute and others are now building even more complex DNA nanostructures with refined functions, such as smart biomedical analysis.8

Conventional assembly of such DNA nanostructures exploits the hybridization of a DNA strand to part of its complementary strand. In addition, we have discovered that DNA nanostructures called nanoflowers because they resemble a ring of nanosize petals, can be self-assembled through liquid crystallization of DNA, which typically occurs at high concentrations of the nucleic acid.9 Importantly, these DNA nanostructures can be readily incorporated with components possessing multiple functionalities, such as aptamers for specific recognition, fluorophores for molecular imaging, and DNA therapeutics for disease therapy.

Another example of novel nanoparticles is DNA micelles, three-dimensional nanostructures that can be readily modified to include aptamers for specific cell-type recognition, or DNA antisense for gene silencing. The lipid core and sphere of projecting nucleic acids can enter cells without any transfection agents and have high resistance to nuclease digestion, making them ideal candidates for drug delivery and cancer therapy.

Researchers are developing many types of nanoscale magic bullets that can specifically deliver drugs into target cells or tissues.

Such advances in targeting are now making it possible to deliver combinations of drugs and ensure that they reach target cells simultaneously. Paula Hammond and Michael Yaffe of MIT recently reported a liposome-based combination chemotherapy delivery system that can simultaneously deliver two synergistic chemotherapeutic drugs, erlotinib and doxorubicin, for enhanced tumor killing.10 Erlotinib, an inhibitor of epidermal growth factor receptor (EGFR), promotes the dynamic rewiring of apoptotic pathways, which then sensitizes cancer cells to subsequent exposure to the DNA-damaging agent doxorubicin. By incorporating erlotinib, a hydrophobic molecule, into the lipid bilayer shell while packaging the hydrophilic doxorubicin inside of the liposomes, the researchers achieved the desired time sequence of drug releasefirst erlotinib, then doxorubicinin a one-two punch against the cancer. They also demonstrated that the efficiency of drug delivery to cancer cells was enhanced by coating the liposomes with folate.

Scientists are also engineering smart nanoparticles, which activate only in the disease microenvironment. For example, George Church of Harvard Medical School and the Wyss Institute and colleagues invented a logic-gated DNA nanocapsule that they programmed to deliver drugs inside cells only when a specific panel of disease biomarkers is overexpressed on the cell surface.11 And Donald Ingbers group, also at Harvard Medical School and the Wyss Institute, developed microscale aggregates of thrombolytic-drug-coated nanoparticles that break apart under the abnormally high fluid shear stress of narrowed blood vessels and then bind and dissolve the problematic clot.12

With these and other nanoplatforms for targeted drug delivery being tested in animal models, medicine is now approaching the prototypic magic bullet, sparing healthy tissue while exterminating disease.

In addition to serving as mere drug carriers that deliver the toxic payload to target cells, nanomaterials can themselves function as therapeutics. For example, thermal energy is emerging as an important means of therapy, and many gold nanomaterials can convert photons into thermal energy for targeted photothermal therapy. Taking advantage of these properties, we conjugated aptamers onto the surfaces of gold-silver nanorods, which efficiently absorb near-infrared light and convert energy from photons to heat. These aptamer-conjugated nanorods were capable of selectively binding to target cells in culture and inducing dramatic cytotoxicity by converting laser light to heat.13

Magnetic nanoparticles are also attractive for their ability to mediate heat induction. Jinwoo Cheon of Yonsei University in Korea developed coreshell magnetic nanoparticles, which efficiently generated thermal energy by a magnetization-reversal process as these nanoparticles returned to their relaxed states under an external, alternating-current magnetic field.14 Using this technology, Cheon and his colleagues saw dramatic tumor regression in a mouse model.A third type of nanosize therapeutic involves cytotoxic polymers. For example, we synthesized a nucleotide-like molecule called an acrydite with an attached DNA aptamer that specifically binds to and enters target cancer cells.15 The acrydite molecules in the resultant acrydite-aptamer conjugates polymerized with each other to form an aptamer-decorated molecular string that led to cytotoxicity in target cancer cells, including those exhibiting multidrug resistance, a common challenge in cancer chemotherapy.

Many other subfields have been advanced by recent developments in nanomedicine, including tissue engineering and regenerative medicine, medical devices, and vaccines. We must proceed with caution until these different technologies prove safe in patients, but nanomedicine is now poised to make a tremendous impact on health care and the practice of clinical medicine.

Guizhi Zhu is a postdoctoral associate in the Department of Chemistry and at the Health Cancer Center of the University of Florida. Weihong Tan is a professor and associate director of the Center for Research at the Bio/Nano Interface at the University of Florida. He also serves as the director of the Molecular Science and Biomedicine Laboratory at Hunan University in China, where Lei Mei is a graduate student.

See more here:
Nanomedicine | The Scientist Magazine

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Conferences | Nanotechnology Events …

About Conference

ME Conferences invites all the participants from all over the world to attendNanomedicine and Nanotechnology in Health CareDuring 17-19 September, 2018 at Abu Dhabi, UAE. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. And it provides an opportunity to learn about the complexity of the Diseases, discuss interventional procedures, look at new and advances in Nanotechnology and their efficiency and efficacy in diagnosing and treating various diseases and also in Healthcare treatments.

ME Conferences organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 1,00,000 eminent personalities, reputed scientists as editorial board and organizing committee members. ME Conferences journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.ME Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, international workshops, world class international exhibitions and poster presentations.

Why to attend?

This Conference Nanomedicinemeet 2018 will focus on Healthcare and Medicine. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields Nanotechnology and Engineering, Medical Nanotechnology, Tissue Engineering are hallmarks of this conference. Nanomedicinemeet-2018 is an exciting opportunity to showcase the modern technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanotechnology, MaterialScienceand other interesting topics.

Target Audience:

The termNano medicineencompasses a broad range of technologies and materials. Types of nanomaterials that have been investigated for use as drugs,, drug carriersor other Nonmedical agents. There has been steep growth in development of devices that integrate nanomaterials or other nanotechnology. Thenanotechnology-based medical devices market is categorized into three major segments, namely, therapeutic applications, diagnostics applications, and research applications. Rising incidence of lifestyle and age-related disorders (such as cardiovascular and hearing disorders) has contributed significantly to the growth of the nanotechnology-based active implantable devices market. Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medicine, communications and genomics. On the surface, miniaturization provides cost effective and more rapidlyfunctioningbiological components. Less obvious though is the fact that Nanometer sized objects also possess remarkableself-ordering and assemblybehaviors under the control of forces quite different from macro objects.

Advances in technology have increased our ability to manipulate the world around us . Nanotechnology is rapidly emerging within the realm of medicine. Nanomedicine is the process of diagnosing, treating, and preventing disease andtraumatic injury, of relieving pain, and of preserving and improving human health, using molecular tools and molecular knowledge of the human body. An exciting and promising area of Nano technological development is the building of Nanorobots. Highly precise positioning techniques are required in Miniaturing in chip technology, optics , micro mechanic, medicine , gene and biotechnology. The new manipulation technology is the desire to enter the micro and Nano world not only by viewing but also acting, alteringmicro andNanosized objects. Nanorobots plays a critical roles for many applications in the human body, such astargetingtumoral lesionsfor therapeutic purposes, miniaturization of the power source with an effective onboard controllable propulsion and steering system have prevented the implementation of such mobile robots.

The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed. It is an emerging modality for the treatment of a variety of diseases that require the killing of pathological cells (e.g. cancer cells or infectious micro-organisms) or the removal of unwanted tissue (e.g. neovascularization in the choroid or atherosclerotic plaques in the arteries). It is based on the excitation of nontoxic photosensitizers.Photodynamic therapy(PDT) uses the combination of dyes with visible light to produce reactive oxygen species and kill bacteria and destroy unwanted tissue. Nanotechnology plays a great role insolubilizing thephotosensitizers, metal nanoparticles can carry out Plasmon resonance enhancement, andfullerenescan act as photosensitizers, themselves.

Nanotechnology is becoming increasingly important for the several sectors. Promising results and applications are already being developed in the areas of nutrient delivery systems through bioactive Nano encapsulation,biosensorsto detect and quantifypathogens organic compounds. The sensitivity and performance of biosensors is being improved by using nanomaterials for their construction. The use of these nanomaterials has allowed the introduction of many new signal transduction technologies in biosensors. Many scientists have involved themselves to know the application and the benefits of nanotechnology in different areas of food industry that include bioactive Nano encapsulation, edible thin film, packages andNano sensors.

Green chemistry and Nano science are both emerging fields that take advantage of molecular-level designing and have enormous potential for advancing our science. Nano science is the study of materials that are on the length-scale of 100 nanometers or smaller and have properties that are dependent on their physical size. The principles of green chemistry can guide responsible development of Nano science, while the new strategies of Nano science can fuel the development ofgreener productsand processes.Phytochemicalsoccluded in tea have been extensively used as dietary supplements and as naturalpharmaceuticalsin the treatment The parallel development of green chemistry and Nano science and the potential synergy of the two fields can lead to more successful and profitable technologies with reduced environmental impacts and improved conservation of resources. In recent years, green synthesis ofmetal nanoparticlesis an interesting issue of the nanoscience.

Nanotechnologyis enabling technology that deals with Nano-meter sized objects. It is expected that nanotechnology will be developed at several levels: materials, devices and systems. The combination of biology and nanotechnology has led to a new generation ofNano devicesthat opens the possibility to characterize the chemical, physical, mechanical, and other molecular properties. And it can be even used to characterize the single molecules or cells at extraordinarily high throughput.Nanoparticleswith distinctive chemical compositions, sizes, shapes, and surface chemistries can be engineered easily and this technique has wide range of applications in biological systems.Utility of nanotechnology to biomedical sciences imply creation of materials and devices designed tointeraction in sub-cellular scaleswith a high degree of specificity.

Biopolymer nanoparticles are offering numerous advantages which embrace the simplicity of their preparation from well-understood biodegradable, biocompatible polymers and their high stability inbiological fluidsduring storage. Since the emergence of Nanotechnology in the past decades, the development and design of organic andbioorganic nanomaterialshas become an important field of research. And several types of polymers have been tested and are used in drug delivery systems; including nanoparticles, dendrimers, capsosomes and micelles. Researchers have found, the synthesized polymers even serves as a good carrier and plays a vital role in carrying a drug. And in other hand they are used in food industries too for food package purposes. There are thousands of organic chemicals are in present in various pharmaceutical to consumer product and are being used in dyes, flavoring agents. It can be explained in organic compounds ranging in diameter from 10 to 1m.Ultrafine particlesare the same asnanoparticlesand between 1 and 100 nanometers in size, fine particles are sized between 100 and 2,500 nanometers, and coarse particles cover a range between 2,500 and 10,000nanometers.

The biological synthesis ofnanoparticlesis synthesis method through which we can control, size and shape of nanoparticles and it increasingly regarded as a rapid, ecofriendly, and easily scaled-up technology. Over the past few years researches have shown their interest inmetallic nanoparticlesand their synthesis has greatly increased. However, drawbacks such as the involvement oftoxic chemicalsand the high-energy requirements of production. Synthesizing living organisms such as bacteria, fungi and plants is an alternative way to overcome the drawbacks. Plant mediated synthesis of nanoparticles is the green chemistry that connects. Generally, metal nanoparticles are synthesized and stabilized by using physical and chemical: the chemical approach, such as chemical reduction,electrochemical techniques,photochemical reactionsin reverse micelles. There is a growing attention to biosynthesis the metal nanoparticles using organisms. Among these organisms, plants seem to be the best candidate and they are suitable for large scale biosynthesis of nanoparticles.

Nanoparticles used asdrug deliveryvehicles are generally below 100 nm , and are coated with different biodegradable materials such as natural or synthetic polymers (PEG,PVA,PLGA,etc.), lipids, or metals , it plays significant role on cancer treatment as well as it holds tremendous potential as an effective drug delivery system. A targeted drug delivery system (TDDS) is a system, which releases the drug in a controlled manner. Nanosystems with different compositions and biological properties have been extensively investigated for drug and gene delivery applications. To achieve efficient drug delivery it is important to understand the interactions ofNanomaterialswith the biological environment, targetingcell-surface receptors, drug release, multiple drug administration, stability of therapeutic agents. Nanotechnology refers to structures roughly in the 1100 nm size regime in at least one dimension. Despite this size restriction, nanotechnology commonly refers to structures that are up to several hundred nanometers in size and that are developed bytop-down or bottom-up engineering of individual components.

Nanosuspention formulation can be used to improve the solubility of the poorly soluble drugs. One of the major problems associated with poorly soluble drugs is very low bioavailability. The Preparation ofNanosuspentionis simple and applicable to all drugs which are water insoluble. It consists of the pure poorly water-soluble drug without any matrix material suspended in dispersion . Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction,crystal engineering, salt formation, solid dispersion, use ofsurfactant, complexation A range of parameters like solubility, stability at room temperature, compatibility with solvent, excipient, andphotostabilityplay a critical role in the successful formulation of drugs. Use of some drug which is potentially restricted because of its toxic side-effects and its poor solubility, making it unsuitable for intravenous use in patients withdrug malabsorption.

Nano medicine drives the convergence of nanotechnology and medicine it is delineated as the application of nanotechnology in healthcare. The field of tissue engineering has developed in phases: initially researchers searched for inert biomaterialsto act solely as replacement structures in the body. Tissue engineering is classified as an associate field of biomaterialsand engineering. It focuses on the use of cellular and material-based therapies aimed attargeted tissue regenerationcaused by traumatic, degenerative, and genetic disorders.It covers a broad range of applications, in practice the term has come to represent applications that repair or replace structural tissues (i.e., bone, cartilage, blood vessels, bladder, etc.). Today, these Nano scale technologies are coming to the forefront in medicine because of their biocompatibility, tissue-specificity, and integration and ability to act as therapeutic carriers.

Polymeric nanoparticles (NPs) are one of the most studied organic strategies for Nano medicine. Intense interest lies in the potential ofpolymeric NPsto revolutionize modern medicine. Polymeric NPs include drug delivery techniques such as conjugation and entrapment of drugs,prodrugs, stimuli-responsive systems,imaging modalities, and theranostics.The use of biodegradable polymeric nanoparticles (NPs) for controlled drug delivery has shown significanttherapeutic potential. Concurrently, targeted delivery technologies are becoming increasingly important as a scientific area of investigation. Polymericnanoparticles-based therapeutics show great promise in the treatment of a wide range of diseases, due to the flexibility in which their structures can be modified, with intricate definition over their compositions, structures and properties. Advances in polymerizationchemistries and the application of reactive, efficient andorthogonal chemicalmodification reactionshave enabled the engineering of multifunctional polymericnanoparticles.

In recent years,microbubbleand Nano bubble technologies have drawn great attention due to their wide applications in many fields of science and technology, such as water treatment,biomedical engineering, and nanomaterials.Nano bubblesexhibit unique characteristics; due to their minute size and high internal pressure, they can remain stable in water for prolonged periods of time. Nanobubbles can be created whengold nanoparticlesare struck by short laser pulses. The short-lived bubbles are very bright and can be made smaller or larger by varying the power of the laser. Because they are visible under a microscope, nanobubbles can be used to either diagnose sick cells or to track the explosions that are destroying them.

Natural productshave been used in medicine for many years. Many top-sellingpharmaceuticalsare natural compounds or their derivatives.. And plant- or microorganism-derived compounds have shown potential as therapeutic agents against cancer, microbial infection, inflammation, and other disease conditions. Natural products had huge success in the post-World War II era as antibiotics, and the two terms have become synonymous.While large pharmaceutical companies have favored screening synthetic compound libraries for drug discovery, small companies have started to explore natural products uses against cancer, microbial infection, inflammation, and other diseases.The incorporation of nanoparticles into a delivery system for natural products would be a major advance in the efforts to increase their therapeutic effects. Recently, advances have been made showing that nanoparticles can significantly increase the bioavailability of natural products bothin vitro and in vivo.

Nanoscience and nanotechnology are new frontiers of this century and food nanotechnology is an emerging technology. Food technology is regarded as one of the industry sectors where nanotechnology will play an important role in the future. The development of new products and applications involving nanotechnologies holds great promise in different industrial sectors, Nanotechnology may revolutionize the food industry by providing stronger, high-barrier packaging materials, more potentantimicrobial agents. Several possibilities exist to exploit the benefits of nanotechnologies during different phases of the food chain with the aim to enhance animal nutrition and health. Several complex set of engineering and scientific challenges in the food and bioprocessing industries for manufacturing high quality and safe food through efficient and sustainable means can be solved through nanotechnology. Bacteria identification and food quality monitoring using biosensors; intelligent, active, and smart food packaging systems; and Nanoencapsulationofbioactive food compoundsare few examples of emerging applications of nanotechnology for the food industry.

The main current applications of Nanotechnology for surgeons are in the areas of development of surgical implants using Nanomaterials, Imaging, Drug Delivery and development of Tissue Engineering products, such as scaffolds with enhanced materialcell interaction. An example of this is the development of a scaffold for delivery of stem cells to replace defective retinal pigmented epithelial cells in age-related Macular Degeneration. In Dentistry research has been done, liposomal Nanoparticles that contained collagenase and performed tests with them in rats, and found compared to conventional surgery, collagenase weakened the collagen fibers, making it easier to shift the teeth afterward with braces.

Nanoparticles with their unique size-dependent properties are at the forefront of advanced material engineering applications in several fields. Metals, non-metals, bio-ceramics, and manypolymeric materialsare used to produce nanoparticles of the respective materials. These are functional in producing liposomes, PEG and many more. Due to their small size nanoparticles has found to be interacting with human bodies same like of gases. Nanoparticles of the same composition can display behavioral differences when interacting with different environments. Nanoparticles can enter the human body via inhalation, ingestion, or skin contact. The range of pathologiesrelated to exposure tonanoparticles encompasses respiratoryand even several organs and leads to diseases. Accurate in vitro assessment ofnanoparticle cytotoxicityrequires a careful selection of the test systems. Due to high adsorption capacity and optical activity, engineered nanoparticles are highly potential in influencing classical cytotoxicity assays.

One of the exciting features of nanotechnology is its utility in the field of Nano medicine, therapeutics, and medical devices . When these small size materials are introduced into biological systems, their extremely small size and their unique Nano scale properties make it possible to use them as delivery vectors and probes for biological diagnostics,bioimagingand therapeutics. In fact, when size decreases, thesurface area to volume ratioof materials becomes very large, so that a vast suitable surface is available forchemical interactions withbiomolecules. This critically implied that nanotechnology is facing a transition into the tangible advancement ofhuman therapeutics. Recently, There are multiple clinical trials of nanomaterials have done; both for therapeutics and for medical devices.

Related conferences: Nanomedicine Conferences | Nanotechnology Events | Nano Healthcare Congress | Nanomedicine Meet | Nanoscience Event | Nanoengineering Conference | Tissue Engineering Meeting

Related Societies:

USA:International Organization of Materials, International Association of Nanotechnology, Graphene Stakeholders Association, Nano Science and Technology Institute (NSTI),NanoBusiness Commercialization Association, Alliance for Nanotechnology in Cancer,International association of nanotechnology,National Institute for Nanotechnology, Waterloo Institute for Nanotechnology, The Institute for Molecular Manufacturing (IMM),NanoBusiness Alliance, Nanotechnology and Nanoscience Student Association (NANSA),Nano Science and Technology Institute (NSTI),National Cancer Institute, National Nanotechnology Initiative,American Nano society, Metals and Minerals Societies, Society for Advancement of Material and process Engineering,American Composites Manufacturers Association, Brazilian Composites Materials Association,Canadian Biomaterials Society, American Institute of Aeronautics and Astronautics (AIAA).

Europe:International Union of Crystallography, European Nanoscience and Nanotechnology Association (ENNA),German Association of Nanotechnology, Nanotechnology Industries Association, The Institute of Nanotechnology (IoN), Nanotechnology Industries Association (NIA),Russian Society of Scanning Probe Microscopy and Nanotechnology, Society of Nanoscience and Nanotechnology, Federation of Materials Societies, Society for Biomaterials, Federation of European Materials Societies

Asia-Pacific & Middle East:Nano Technology Research Association (NTRA), Asian Nanoscience and Nanotechnology Association (ANNA), Nanoscience & Nanotechnology, ASPEN-Asian society of precision engineering and nanotechology, The International Association of Nanotechnology (IANT), Iran Nanotechnology Initiative Council (INIC), National Institutes of Health, Society of Materials Science, Japan Society for Composite Materials, Australasian Society for Biomaterials and Tissue Engineering, Australasian Ceramic Society, Materials Research Society, National Centre for Nanoscience and Technology.

Theme: Role of Nanotechnology in Humans life

Summary:

The field of Nanotechnology has recently emerged as the most commercially viable technology of this century because of its wide-ranging applications in our daily lives. Man-made Nanostructured materials such as fullerenes, nanoparticles, Nano powders, Nanotubes, Nanowires, Nanorods, Nano-fibers, Quantum dots, Dendrimers, Nano clusters, Nanocrystals, and Nanocomposites are globally produced in large quantities due to their wide potential applications, e.g., in skincare and consumer products, healthcare, electronics, photonics, biotechnology, engineering products, Pharmaceuticals, drug delivery, and agriculture. Many emerging economies such as Brazil, China, India, Iran, UAE, Malaysia, Mexico, Singapore and South Africa have ambitious research and development (R&D) plans for Nanotechnology.A group of scientists who have mapped out the uses of Nanotechnology and the needs of global health argue that Nano medicine is relevant for the developing world. They surveyed researchers worldwide and concluded that Nanotechnology could greatly contribute to meeting the Millennium Development Goals for health.

Importance and scope:

Nanotechnologyis becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including Nano scale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies. Universities also have begun to offer dedicated Nano medicine degree programs (example:MSc program in Nanotechnology for Medicine and Health Care). Nanotechnology will be getting to be progressively prevalent these times Around learners. Actually, if you follow again of the Inception about nanotechnology, you will discover that Ayurveda need long been utilizing gold Also silver nanoparticles, known as bhasmas, to treat Different therapeutic ailments. Presently, nanotechnology may be generally utilized within huge numbers industries, going from cosmetics, agriculture, and materials should pharmaceutical Also human services. Nanomedicine may be the provision for nanotechnology for those diagnoses, detection, and medicine Also aversion of illnesses. Presently there need aid various items on the business that would the outcome from claiming nanotechnology. Talking for scratching the surface, we likewise have Nano auto wax that fills done the individuals minor cracks more successfully Furthermore provides for you a shinier vehicle. There need aid likewise Nano items accessible with stay with your eyewear What’s more different optical units cleaner, dryer, What’s more that’s only the tip of the iceberg tough.

Conference highlights:

Why in Abu Dhabi?

Abu Dhabi is the federal capital and centre of government in the United Arab Emirates sits off the mainland on an island in the Persian (Arabian) Gulf. It is the largest city of the Emirate of Abu Dhabi and one of the most modern cities in the world. It is a well-ordered, industrious city with a pretty waterside location. Innovative Nano Technology LLC was founded in the beginning of 2016 in Al Ain City, Abu Dhabi, United Arab Emirates. It was established with the goal of taking a leading role in the field of Nano Technology Based Coatings, and is considered as one of the first Companies who offer the new Nano technology based Coatings in the region.

Why to attend?

United Arab Emirates has a number of universities that offer research and educational opportunities in nanotechnology. United Arab Emirates University, The first and foremost comprehensive National University in the United Arab Emirates. eFORS office is the University consultancy office within the college of engineering that deals with several science and technology issues including Biochemical and Biopharmaceutical Processes and Bioengineering and Nanotechnology. Reports released during October 2012 revealed that the worlds second largest foundry, Globalfoundries has agreed to partner with Masdar Institute to develop Abu Dhabi as a centre for semiconductor R&D and manufacturing excellence. In September, the company allowed students and professors to use its technology facilities at its Abu Dhabi branch. The facilities have a laboratory-like environment with powerful production servers, engineering work stations and a high-speed data network that can be used for enabling remote access to very advanced nanotechnology engineering systems

Technology domains of patent applications in UAE

This graph shows the global Nanomedicine market size, measured in terms of revenues, such as sales revenues, grants revenues, and milestones. From2006to date, a steady growth has occurred, which is expected to continue through2014, at aCAGRof13.5% [BCCResearch, Nanotechnology in Medical Applications. The drug delivery market is the largest contributing application segment, whereas biomaterials are the fastest growing application area in this market. Nanomedicine accounts for77Marketed Products Worldwide, representing an Industry with an estimated market $249.9Billion by2016[ETPNdata,BCC].

Globally, the industry players would centering essentially once R&D to get Regard for Different clinical trials for future Nanodrugs with a chance to be economically accessible in the business sector. If a chance to be generally arranged for exactly of the most punctual What’s more The greater part essential requisitions of Nano medicine for regions for example, gene treatment and tissue building. The a greater amount propelled requisitions for Nano medicine will pose interesting tests As far as order Furthermore support about exploratory dexterity.

Nano medicine market :

Nano-enabled medical products beganappearing on the market over a decade ago and some have become best-sellers in theirtherapeutic categories. The main areas in which Nanomedical products have made animpact are cancer, CNS diseases, cardiovascular disease, and infection control. At present, cancer is one of the largesttherapeutic areas in which Nano-enabled products have made major contributions; theseinclude Abraxane, Depocyt, Oncospar, Doxil,and Neulasta. Cancer is a prime focus forNano pharmaceutical R&D, and companieswith clinical-stage developments in this fieldinclude Celgene, Access, Camurus, andCytimmune. Treatments for CNS disorders includingAlzheimers disease and stroke also feature prominently in Nano therapeutic research,seeking to build on achievements already posted by products such as Tysabri, Copazone,and Diprivan. According to BCC Research,this is a field hungry for successfultherapeutic advances and annual growth fromexisting and advanced pipeline products isexpected to reach 16% over the next 5 years.

Nanotechnology Companies in Asia and Middle East:

Nano Congress 2017

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Sponsors for making Nano Congress 2017 Conference the best ever!

The19thNano Congress for Next Generation, hosted by the ME Conferences was held duringAugust 31- September 01, 2017atBrussels, Belgiumbased on the themeNext Generation Nanotechnology Concepts Methodologies Tools and Applications”. Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Nanotechnology who made this event a grand success.

ME Conferences expresses its gratitude to the conference Moderator,namelyDr.Dominique Ausserrefor taking up the responsibility to coordinate during the sessions. We are indebted to your support.

Similarly we also extend our appreciation towards our Poster judge namely,Dr. Arturs Medvids.

The conference was initiated with theHonorable presenceof theKeynote forum. The list includes:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Nano Materials Synthesis and Characterisation

Nano Photonics

Molecular Nanotechnology

Nanotechnology and Cosmetics

Nanotechnology in Agriculture and Food Industry

Carbon Based Nano materials and Devices

Nanotechnology Safety

Nano Medicine and Nano Biotechnology

Nano Science and Technology

Nano Applications

Nano-electronics

Nano Biomaterials

Nano Biometric

Advanced Nanomaterials

Nano Technology in Tissue Engineering

Nanotech for Energy and Environment

Nano Computational Modelling

ME Conferences offers its heartfelt appreciation to organizations such asAllied Academies,Andrew John Publishing Inc.,New York private Equity Forum,Crowd Reviewsand other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. ME Conferences also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and sponsors who supported this event

Read the rest here:
Nanomedicine Conferences | Nanotechnology Events …

Recommendation and review posted by Alexandra Lee Anderson

OMICS International | Open Access Journals | Scientific …

Select JournalSELECT fullname, submit_url FROM `journal_urls` order by fullname Abnormal and Behavioural Psychology Acute and Chronic Disease Reports Advanced Practices in Nursing Advanced Techniques in Biology & Medicine Advancements in Genetic Engineering Advances in Automobile Engineering Advances in Antibiotics & Antibodies Advances in Cancer Prevention Advances in Crop Science and Technology Advances in Dairy Research Advances in Molecular Diagnostics Advances in Pharmacoepidemiology & Drug Safety Advances in Recycling & Waste Management Advances in Robotics & Automation Aerobics & Fitness Agrotechnology Air & Water Borne Diseases Alternative & Integrative Medicine Anatomy & Physiology: Current Research Andrology-Open Access Anesthesiology Communications Angiology: Open Access Annals of Infections and Antibiotics Anthropology Applied Microbiology: Open Access Arabian Journal of Business and Management Review Archives of Parasitology Archives of Science Archives of Surgical Oncology Arts and Social Sciences Journal Atherosclerosis: Open Access Autism-Open Access Bioceramics Development and Applications Biochemistry & Analytical Biochemistry Biochemistry & Pharmacology: Open Access Biochemistry & Physiology: Open Access Bioenergetics: Open Access Biological Systems: Open Access Biology and Medicine Biopolymers Research Biosensors Journal Bipolar Disorder: Open Access Brain Disorders & Therapy Breast Cancer: Current Research Business and Economics Journal Cancer Surgery Cardiovascular Pharmacology: Open Access Cardiovascular Therapy: Open Access Cell & Developmental Biology Cellular and Molecular Biology Chemical Sciences Journal Chemotherapy: Open Access Clinical & Medical Biochemistry Clinical and Experimental Psychology Clinical and Medical Case Reports Clinical Depression Clinical Gastroenterology Journal Clinical Infectious Diseases: Open Access Clinical Microbiology: Open Access Clinical Neuropsychology: Open Access Clinical Pediatrics: Open Access Clinical Pharmacology & Biopharmaceutics Clinical Research on Foot & Ankle Clinics in Mother and Child Health Cloning & Transgenesis Cosmetology & Oro Facial Surgery Current Synthetic and Systems Biology Current Trends in Gynecologic Oncology Dentistry Dermatology and Dermatologic Diseases Dermatology Case Reports Diabetes Case Reports Diagnostic Pathology: Open Access Drug Designing: Open Access Emergency Medicine: Open Access Endocrinology & Metabolic Syndrome Entomology, Ornithology & Herpetology: Current Research Environment Pollution and Climate Change Enzyme Engineering Epidemiology: Open Access Epigenetics Research: Open Access Epilepsy Journal Evidence based Medicine and Practice Family Medicine & Medical Science Research Fermentation Technology Fibromyalgia: Open Access Fisheries and Aquaculture Journal Fluid Mechanics: Open Access Forest Research: Open Access Fungal Genomics & Biology Gene Technology General Medicine: Open Access Global Journal of Nursing & Forensic Studies Global Journal of Technology and Optimization Gynecology & Obstetrics Hair Therapy & Transplantation Health Care : Current Reviews Health Economics & Outcome Research: Open Access Hepatology and Pancreatic Science Hereditary Genetics: Current Research HIV: Current Research Human Genetics & Embryology Hydrology: Current Research Immunochemistry & Immunopathology Immunogenetics: Open Access Immunological Disorders & Immunotherapy Immunology: Current Research Immunome Research Immunotherapy: Open Access Industrial Chemistry Industrial Engineering & Management Innovative Energy & Research Intellectual Property Rights: Open Access Internal Medicine: Open Access International Journal of Accounting Research International Journal of Advance Innovations, Thoughts & Ideas International Journal of Advancements in Technology International Journal of Biomedical Data Mining International Journal of Economics & Management Sciences International Journal of Emergency Mental Health and Human Resilience International Journal of Inflammation, Cancer and Integrative Therapy International Journal of Microscopy International Journal of Neurorehabilitation International Journal of Physical Medicine & Rehabilitation International Journal of Public Health and Safety International Journal of Research and Development in Pharmacy & Life Sciences International Journal of School and Cognitive Psychology International Journal of Sensor Networks and Data Communications International Journal of Swarm Intelligence and Evolutionary Computation International Journal of Waste Resources Irrigation & Drainage Systems Engineering JBR Journal of Clinical Diagnosis and Research JBR Journal of Interdisciplinary Medicine and Dental Science Journal of Accounting & Marketing Journal of Addiction Research & Therapy Journal of Advanced Chemical Engineering Journal of Aeronautics & Aerospace Engineering Journal of Aging Science Journal of Agricultural Science and Food Research Journal of AIDS & Clinical Research Journal of Alcoholism & Drug Dependence Journal of Allergy & Therapy Journal of Alzheimers Disease & Parkinsonism Journal of Analytical & Bioanalytical Techniques Journal of Anesthesia & Clinical Research Journal of Anesthesiology and Pain Research Journal of Animal Health and Behavioural Science Journal of Anthropology Reports Journal of Antimicrobial Agents Journal of Antivirals & Antiretrovirals Journal of Applied & Computational Mathematics Journal of Applied Mechanical Engineering Journal of Applied Pharmacy Journal of Aquaculture Research & Development Journal of Architectural Engineering Technology Journal of Arthritis Journal of Astrobiology & Outreach Journal of Astrophysics & Aerospace Technology Journal of Autacoids and Hormones Journal of Bacteriology & Parasitology Journal of Bioanalysis & Biomedicine Journal of Biochemical and Microbial Toxicology Journal of Biochemistry and Cell Biology Journal of Biodiversity & Endangered Species Journal of Biodiversity, Bioprospecting and Development Journal of Bioengineering & Biomedical Science Journal of Bioengineering and Bioelectronics Journal of Bioequivalence & Bioavailability Journal of Biological and Medical Sciences Journal of Biomedical and Pharmaceutical Sciences Journal of Biomedical Engineering and Medical Devices Journal of Biomedical Systems & Emerging Technologies Journal of Biometrics & Biostatistics Journal of Biomimetics Biomaterials and Tissue Engineering Journal of Biomolecular Research & Therapeutics Journal of Biomusical Engineering Journal of Bioprocessing & Biotechniques Journal of Bioremediation & Biodegradation Journal of Bioresearch Communications Journal of Biosensors & Bioelectronics Journal of Biotechnology & Biomaterials Journal of Bioterrorism & Biodefense Journal of Blood & Lymph Journal of Blood Disorders & Transfusion Journal of Bone Research Journal of Brain Research Journal of Business & Financial Affairs Journal of Cancer Clinical Trials Journal of Cancer Diagnosis Journal of Cancer Research and Immuno-Oncology Journal of Cancer Science & Therapy Journal of Cancer Science and Research Journal of Carcinogenesis & Mutagenesis Journal of Cardiac and Pulmonary Rehabilitation Journal of Cardiovascular Diseases & Diagnosis Journal of Cell Biology & Immunology Journal of Cell Science & Therapy Journal of Cell Science and Apoptosis Journal of Cell Signaling Journal of Cellular and Molecular Pharmacology Journal of Chemical Biology & Therapeutics Journal of Chemical Engineering & Process Technology Journal of Child and Adolescent Behavior Journal of Chromatography & Separation Techniques Journal of Civil & Environmental Engineering Journal of Civil & Legal Sciences Journal of Climatology & Weather Forecasting Journal of Clinical & Cellular Immunology Journal of Clinical & Experimental Cardiology Journal of Clinical & Experimental Dermatology Research Journal of Clinical & Experimental Neuroimmunology Journal of Clinical & Experimental Ophthalmology Journal of Clinical & Experimental Pathology Journal of Clinical & Experimental Pharmacology Journal of Clinical & Medical Genomics Journal of Clinical and Experimental Endocrinology Journal of Clinical and Experimental Transplantation Journal of Clinical and Medical Sciences Journal of Clinical Anesthesiology: Open Access Journal of Clinical Case Reports Journal of Clinical Chemistry and Laboratory Medicine Journal of Clinical Diabetes Journal of Clinical Infectious Diseases & Practice Journal of Clinical Microbiology and Antimicrobials Journal of Clinical Neurology and Neurosurgery Journal of Clinical Research Journal of Clinical Research & Bioethics Journal of Clinical Respiratory Diseases and Care Journal of Clinical Toxicology Journal of Clinical Trials Journal of Coastal Zone Management Journal of Colitis & Diverticulitis Journal of Communication Disorders, Deaf Studies & Hearing Aids Journal of Community & Public Health Nursing Journal of Community Medicine & Health Education Journal of Computer Science & Systems Biology Journal of Congenital Disorders Journal of Coronary Heart Diseases Journal of Cosmetology & Trichology Journal of Cytokine Biology Journal of Cytology & Histology Journal of Data Mining in Genomics & Proteomics Journal of Defense Management Journal of Dementia Journal of Dental Pathology and Medicine Journal of Dental Science and Medicine Journal of Depression and Anxiety Journal of Dermatitis Journal of Developing Drugs Journal of Diabetes & Clinical Practice Journal of Diabetes & Metabolism Journal of Diabetic Complications & Medicine Journal of Down Syndrome & Chromosome Abnormalities Journal of Drug Metabolism & Toxicology Journal of Earth Science & Climatic Change Journal of Ecology and Toxicology Journal of Ecosystem & Ecography Journal of Electrical & Electronic Systems Journal of Entrepreneurship & Organization Management Journal of Environmental & Analytical Toxicology Journal of Environmental Analytical Chemistry Journal of Environmental Hazards Journal of Ergonomics Journal of Experimental Food Chemistry Journal of Eye Diseases and Disorders Journal of Fertilization: In Vitro – IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology Journal of Fisheries & Livestock Production Journal of Food Processing & Technology Journal of Food: Microbiology, Safety & Hygiene Journal of Forensic Biomechanics Journal of Forensic Medicine Journal of Forensic Pathology Journal of Forensic Psychology Journal of Forensic Research Journal of Formulation Science & Bioavailability Journal of Fundamentals of Renewable Energy and Applications Journal of Gastrointestinal & Digestive System Journal of Gastrointestinal Cancer and Stromal Tumors Journal of General Practice Journal of Generalized Lie Theory and Applications Journal of Genetic Syndromes & Gene Therapy Journal of Genetics and DNA Research Journal of Genetics and Genomes Journal of Genome Journal of Geography & Natural Disasters Journal of Geology & Geophysics Journal of Gerontology & Geriatric Research Journal of Global Economics Journal of Glycobiology Journal of Glycomics & Lipidomics Journal of Health & Medical Informatics Journal of Health Care and Prevention Journal of Health Education Research & Development Journal of Hematology & Thromboembolic Diseases Journal of Hepatology and Gastrointestinal disorders Journal of Horticulture Journal of Hotel & Business Management Journal of HPV and Cervical Cancer Journal of Hypertension: Open Access Journal of Immunobiology Journal of Infectious Disease and Pathology Journal of Infectious Diseases & Preventive Medicine Journal of Infectious Diseases & Therapy Journal of Infectious Diseases and Diagnosis Journal of Infectious Diseases and Medicine Journal of Inflammatory Bowel Diseases & Disorders Journal of Information Technology & Software Engineering Journal of Integrative Oncology Journal of Interventional and General Cardiology Journal of Kidney Journal of Lasers, Optics & Photonics Journal of Leukemia Journal of Liver Journal of Lung Cancer Diagnosis & Treatment Journal of Lung Diseases & Treatment Journal of Marine Science: Research & Development Journal of Mass Communication & Journalism Journal of Material Sciences & Engineering Journal of Materials Science and Nanomaterials Journal of Medical & Surgical Pathology Journal of Medical Diagnostic Methods Journal of Medical Implants & Surgery Journal of Medical Microbiology & Diagnosis Journal of Medical Physiology & Therapeutics Journal of Membrane Science & Technology Journal of Meningitis Journal of Mental Disorders and Treatment Journal of Metabolic Syndrome Journal of Microbial & Biochemical Technology Journal of Microbial Pathogenesis Journal of Microbiology and Pathology Journal of Molecular and Genetic Medicine Journal of Molecular Biomarkers & Diagnosis Journal of Molecular Histology & Medical Physiology Journal of Molecular Imaging & Dynamics Journal of Molecular Immunology Journal of Molecular Pathology and Biochemistry Journal of Molecular Pharmaceutics & Organic Process Research Journal of Morphology and Anatomy Journal of Mucosal Immunology Research Journal of Multiple Sclerosis Journal of Nanomedicine & Biotherapeutic Discovery Journal of Nanomedicine & Nanotechnology Journal of Nanosciences: Current Research Journal of Neonatal Biology Journal of Nephrology & Therapeutics Journal of Neuro-Ophthalmology Research Journal of Neuroendocrinology Research Journal of Neuroinfectious Diseases Journal of Neurological Disorders Journal of Neurology & Neurophysiology Journal of Neuroscience and Neuropharmacology Journal of Next Generation Sequencing & Applications Journal of Novel Physiotherapies Journal of Nuclear Medicine & Radiation Therapy Journal of Nursing & Care Journal of Nutrition & Food Sciences Journal of Nutrition & Weight Loss Journal of Nutrition and Dietetics Journal of Nutrition Science Research Journal of Nutritional Disorders & Therapy Journal of Obesity & Weight Loss Therapy Journal of Obesity and Metabolism Journal of Oceanography and Marine Research Journal of Ocular Infection and Inflammation Journal of Odontology Journal of Oncology Medicine & Practice Journal of Oncology Research and Treatment Journal of Oncology Translational Research Journal of Oral Hygiene & Health Journal of Orthopedic Oncology Journal of Osteoporosis and Physical Activity Journal of Paediatric Medicine & Surgery Journal of Pain & Relief Journal of Pain Management & Medicine Journal of Palliative Care & Medicine Journal of Patient Care Journal of Pediatric Neurological Disorders Journal of Pediatric Neurology and Medicine Journal of Perioperative & Critical Intensive Care Nursing Journal of Perioperative Medicine Journal of Petroleum & Environmental Biotechnology Journal of Pharmaceutical Care & Health Systems Journal of Pharmacogenomics & Pharmacoproteomics Journal of Pharmacognosy & Natural Products Journal of Pharmacokinetics & Experimental Therapeutics Journal of Pharmacological Reports Journal of Pharmacovigilance Journal of Phonetics & Audiology Journal of Phylogenetics & Evolutionary Biology Journal of Physical Chemistry & Biophysics Journal of Physical Mathematics Journal of Physiotherapy & Physical Rehabilitation Journal of Phytochemistry & Biochemistry Journal of Pituitary Research & Treatment Journal of Plant Biochemistry & Physiology Journal of Plant Genetics and Breeding Journal of Plant Pathology & Microbiology Journal of Political Sciences & Public Affairs Journal of Pollution Journal of Pollution Effects & Control Journal of Powder Metallurgy & Mining Journal of Pregnancy and Child Health Journal of Probiotics & Health Journal of Prostate Cancer Journal of Proteomics & Bioinformatics Journal of Psychiatry Journal of Psychological Abnormalities Journal of Psychology & Psychotherapy Journal of Pulmonary & Respiratory Medicine Journal of Pulmonology and Respiratory Diseases Journal of Remote Sensing & GIS Journal of Reproductive Biomedicine Journal of Research and Development Journal of Respiratory Medicine Journal of Sleep Disorders & Therapy Journal of Socialomics Journal of Speech Pathology & Therapy Journal of Spine Journal of Sports Medicine & Doping Studies Journal of Steel Structures & Construction Journal of Stem Cell Research & Therapy Journal of Steroids & Hormonal Science Journal of Stock & Forex Trading Journal of Surgery Journal of Surgery and Anesthesia Journal of Surgical Pathology and Diagnosis Journal of Telecommunications System & Management Journal of Textile Science & Engineering Journal of Theoretical & Computational Science Journal of Thermodynamics & Catalysis Journal of Thrombosis and Circulation: Open Access Journal of Thyroid Disorders & Therapy Journal of Tissue Science & Engineering Journal of Tourism & Hospitality Journal of Traditional Medicine & Clinical Naturopathy Journal of Transplantation Technologies & Research Journal of Tropical Diseases & Public Health Journal of Tuberculosis and Therapeutics Journal of Tumor Research Journal of Tumour Research & Reports Journal of Vaccines & Vaccination Journal of Vascular Medicine & Surgery Journal of Vasculitis Journal of Veterinary Medicine and Health Journal of Veterinary Pathology Research Journal of Veterinary Science & Technology Journal of Womens Health Care Journal of Yoga & Physical Therapy Lovotics Lupus: Open Access Malaria Control & Elimination Mass Spectrometry & Purification Techniques Maternal and Pediatric Nutrition Medical & Surgical Urology Medical Reports & Case Studies Medical Safety & Global Health Medicinal & Aromatic Plants Medicinal Chemistry Metabolomics:Open Access Modern Chemistry & Applications Molecular Biology: Open Access Mycobacterial Diseases Natural Products Chemistry & Research Neonatal and Pediatric Medicine Neuroscience and Psychiatry: Open Access Occupational Medicine & Health Affairs Oil & Gas Research OMICS Journal of Radiology Oncology & Cancer Case Reports Optometry: Open Access Oral Health and Dental Management Oral Health Case Reports Organic Chemistry: Current Research Orthopedic & Muscular System: Current Research Otolaryngology: Open Access Pancreatic Disorders & Therapy Pediatric Dental Care Pediatrics & Therapeutics Pharmaceutica Analytica Acta Pharmaceutical Analytical Chemistry: Open Access Pharmaceutical Regulatory Affairs: Open Access Pharmacoeconomics: Open Access Poultry, Fisheries & Wildlife Sciences Primary Healthcare: Open Access Psychology and Psychiatry: Open access Reconstructive Surgery & Anaplastology Reports in Disease Markers Reports in Thyroid Research Reproductive System & Sexual Disorders: Current Research Research and Reports in Medical Sciences Research and reviews on Pathogens Review of Public Administration and Management Rheology: Open Access Rheumatology: Current Research Rice Research: Open Access Single Cell Biology Sociology and Criminology-Open Access Surgery: Current Research The Neurologist: Clinical & Therapeutics Journal The Psychiatrist : Clinical and Therapeutic Journal Toxicology: Open Access Transcriptomics: Open Access Translational Medicine Transplant Reports : Open Access Trauma & Treatment Tropical Medicine & Surgery Virology & Mycology Virology: Current Research Vitamins & Minerals World Journal of Pharmacology and Toxicology

Read more from the original source:
OMICS International | Open Access Journals | Scientific …

Recommendation and review posted by Alexandra Lee Anderson

What is Nanomedicine? : Center for Nanomedicine

Nanomedicine is defined as the medical application of nanotechnology. Nanomedicine can include a wide range of applications, including biosensors, tissue engineering, diagnostic devices, and many others. In the Center for Nanomedicine at Johns Hopkins, we focus on harnessing nanotechnology to more effectively diagnose, treat, and prevent various diseases. Our entire bodies are exposed to the medicines that we take, which can lead to unpleasant side effects and minimize the amount of medicine that reaches the places where it is needed. Medications can be more efficiently delivered to the site of action using nanotechnology, resulting in improved outcomes with less medication.

For example, treating cancer with current chemotherapy delivery techniques is like spraying an entire rose garden with poison in order to kill a single weed. It would be far more effective to spray a small amount of poison, directly on the weed, and save the roses. In this analogy, a cancer patients hair follicles, immune cells, and epithelia are the roses being poisoned by the chemotherapy. Using nanotechnology, we can direct the chemotherapy to the tumor and minimize exposure to the rest of the body. In addition, our nanotechnologies are more capable of bypassing internal barriers (see Technologies), further improving upon conventional nanotechnologies. Not only is our approach more effective at eradicating tumors (see Cancer under Research), but it also results in much higher quality of life for the patient.

Nanotechnology can also reduce the frequency with which we have to take our medications. Typically, the human body can very quickly and effectively remove medications, reducing the duration of action. For example, the current treatment for age-related macular degeneration (AMD) requires monthly injections into the eye in a clinical setting. However, if the medication is slowly released from the inside of a nanoparticle, the frequency of injection can be reduced to once every 6 months (see Eye under Research). The nanoparticle itself also slowly biodegrades into components that naturally occur in the body, which are also removed from the body after the medication has done its job. This exciting technology is currently being commercialized and moved toward clinical trials (see Commercialization).

Nanomedicine will lead to many more exciting medical breakthroughs. Please explore our various nanotechnology platforms and the numerous areas in which we are pursuing nanomedicine-based medical solutions.

See the original post here:
What is Nanomedicine? : Center for Nanomedicine

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine | medicine | Britannica.com

Nanomedicine, branch of medicine that seeks to apply nanotechnologythat is, the manipulation and manufacture of materials and devices that are smaller than 1 nanometre [0.0000001 cm] in sizeto the prevention of disease and to imaging, diagnosis, monitoring, treatment, repair, and regeneration of biological systems.

Although nanomedicine remains in its early stages, a number of nanomedical applications have been developed. Research thus far has focused on the development of biosensors to aid in diagnostics and vehicles to administer vaccines, medications, and genetic therapy, including the development of nanocapsules to aid in cancer treatment.

An offshoot of nanotechnology, nanomedicine is an emerging field and had garnered interest as a site for global research and development, which gives the field academic and commercial legitimacy. Funding for nanomedicine research comes both from public and private sources, and the leading investors are the United States, the United Kingdom, Germany, and Japan. In terms of the volume of nanomedicine research, these countries are joined by China, France, India, Brazil, Russia, and India.

Working at the molecular-size scale, nanomedicine is animated with promises of the seamless integration of biology and technology, the eradication of disease through personalized medicine, targeted drug delivery, regenerative medicine, as well as nanomachinery that can substitute portions of cells. Although many of these visions may not come to fruition, some nanomedicine applications have become reality, with the potential to radically transform the practice of medicine, as well as current understandings of the health, disease, and biologyissues that are of vital importance for contemporary societies. The fields global market share totalled some $78 billion dollars in 2012, driven by technological advancements. By the end of the decade, the market is expected to grow to nearly $200 billion.

Nanomedicine derives much of its rhetorical, technological, and scientific strength from the scale on which it operates (1 to 100 nanometers), the size of molecules and biochemical functions. The term nanomedicine emerged in 1999, the year when American scientist Robert A. Freitas Jr. published Nanomedicine: Basic Capabilities, the first of two volumes he dedicated to the subject.

Extending American scientist K. Eric Drexlers vision of molecular assemblers with respect to nanotechnology, nanomedicine was depicted as facilitating the creation of nanobot devices (nanoscale-sized automatons) that would navigate the human body searching for and clearing disease. Although much of this compelling imagery still remains unrealized, it underscores the underlying vision of doctors being able to search and destroy diseased cells, or of nanomachines that substitute biological parts, which still drives portrayals of the field. Such illustrations remain integral to the field, being used by scientists, funding agencies, and the media alike.

Attesting to the fields actuality are numerous dedicated scientific and industry-oriented conferences, peer-reviewed scientific journals, professional societies, and a growing number of companies. However, nanomedicines identity, scope, and goals are a matter of controversy. In 2006, for instance, the prestigious journal Nature Materials discussed the ongoing struggle of policy makers to understand if nanomedicine is a rhetorical issue or a solution to a real problem. This ambivalence is reflected in the numerous definitions of nanomedicine that can be found in scientific literature, that range from complicated drugs to the above mentioned nanobots. Despite the lack of a shared definition, there is a general agreement that nanomedicine entails the application of nanotechnology in medicine and that it will profoundly impact medical practice.

A further topic of debate is nanomedicines genealogy, in particular its connections to molecular medicine and nanotechnology. The case of nanotechnology is exemplary: on one hand, its potentialin terms of science but also in regard to funding and recognitionis often mobilized by nanomedicine proponents; on the other, there is an attempt to distance nanomedicine from nanotechnology, for fear of being damaged by the perceived hype that surrounds it. The push is then for nanomedicine to emerge not as a subdiscipline of nanotechnology but as a parallel field.

Although nanomedicine research and development is actively pursued in numerous countries, the United States, the EU (particularly Germany), and Japan have made significant contributions from the fields outset. This is reflected both in the number of articles published and in that of patents filed, both of which have grown exponentially since 2004. By 2012, however, nanomedicine research in China grew with respect to publications in the field, and the country ranked second only to the United States in the number of research articles published.

In 2004, two U.S. funding agenciesthe National Institutes of Health and the National Cancer Instituteidentified nanomedicine as a priority research area allocating $144 million and $80 million, respectively, to its study. In the EU meanwhile, public granting institutions did not formally recognize nanomedicine as a field, providing instead funding for research that falls under the headers of nanotechnology and health. Such lack of coordination had been the target of critiques by the European Science Foundation (ESF), warning that it would result in lost medical benefits. In spite of this, the EU ranked first in number of nanomedicine articles published and in 2007 the Seventh Framework Programme (FP7) allocated 250 million to nanomedicine research. Such work has also been heavily funded by the private sector. A study led by the European Science and Technology Observatory found that over 200 European companies were researching and developing nanomedicine applications, many of which were coordinating their efforts.

Much of nanomedicine research is application oriented, emphasizing methods to transfer it from the laboratory to the bedside. In 2005 the ESF pointed to four main subfields in nanomedicine research: analytical tools and nanoimaging, nanomaterials and nanodevices, novel therapeutics and drug delivery systems, and clinical, regulatory, and toxicological issues. Research in analytical tools and nanoimaging seeks to develop noninvasive, reliable, cheap, and highly sensitive tools for in vivo diagnosis and visualization. The ultimate goal is to create fully functional mobile sensors that can be remotely controlled to conduct in vivo, real-time analysis. Research on nanomaterials and nanodevices aims to improve the biocompatibility and mechanical properties of biomaterials used in medicine, so as to create safer implants, substitute damaged cell parts, or stimulate cell growth for tissue engineering and regeneration, to name a few. Work in novel therapeutics and drug delivery systems strives to develop and design nanoparticles and nanostructures that are noninvasive and can target specific diseases, as well as cross biological barriers. Allied with very precise means for diagnosis, these drug delivery systems would enable equally precise site-specific therapeutics and fewer side effects. The area of drug delivery accounts for a large portion of nanomedicines scientific publications.

Finally, the subfield of clinical, regulatory, and toxicological issues lumps together research that examines the field as a whole. Questions of safety and toxicology are prevalent, an issue that is all the more important given that nanomedicine entails introducing newly engineered nanoscale particles, materials, and devices into the human body. Regulatory issues revolve around the management of this newness, with some defending the need for new regulation, and others the ability of systems to deal with it. This subfield should also include other research by social scientists and humanists, namely on the ethics of nanomedicine.

Combined, these subfields build a case for preventive medicine and personalized medicine. Building upon genomics, personalized medicine envisions the possibility of individually tailored diagnostics and therapeutics. Preventive medicine takes this notion further, conjuring the possibility of treating a disease before it manifests itself. If realized, such shifts would have radical impacts on understandings of health, embodiment, and personhood. Questions remain concerning the cost and accessibility of nanomedicine and also about the consequences of diagnostics based on risk propensity or that lack a cure.

Read more from the original source:
Nanomedicine | medicine | Britannica.com

Recommendation and review posted by Alexandra Lee Anderson